
Sign up to save your podcasts
Or


Most people think healthy eating starts at the grocery store.
Jennifer Caraway says it starts long before that—with the farmers willing to dedicate their lives to growing real food.
In Part 1 of our new four-part Food Is Medicine series, Dr. Dan Rubin sits down with Jennifer Caraway, Founder & CEO of JoyBus, to explore the people behind our food system and why supporting local farmers may be one of the most important health decisions we can make.
Jennifer shares the story of Farmer Frank, the first farmer who believed in JoyBus, how local growers helped launch an organization serving cancer patients across Arizona, and why the future of farming—and our health—is at a crossroads.
In this episode:
This is Part 1 of our four-part Food Is Medicine series.
If you enjoyed this conversation, be sure to like, subscribe, and share with someone passionate about nutrition, farming, and the future of health.
#FoodIsMedicine #JoyBus #FarmToTable #CancerCare #Nutrition #HealthyEating #LocalFarmers #RubinOnPoint #FunctionalMedicine #Wellness
To learn more about the Joy Bus visit www.joybus.org
Chapter Timestamps
00:00 Introduction
00:43 Meet Jennifer Caraway
02:22 Introducing the Food Is Medicine Series
04:30 How JoyBus Began
05:13 The Farmer Who Said Yes
07:50 Why Local Farmers Matter
10:08 Does Better Beef Feel Different?
11:42 The Challenges Facing Farmers
16:25 Why We Should Eat Seasonally
18:16 What Happens If Farmers Disappear?
20:59 The Future of Farming
27:53 Legislative Solutions
29:28 Why Food Is Finally Being Taken Seriously
30:35 Final Thoughts
How much can a stool test really tell you about your health?With gut health taking center stage in medicine and social media, it's becoming harder to separate evidence from hype. In this episode of Rubin On Point, Dr. Dan Rubin sits down with Sri Ganeshan, MD, gastroenterologist and Chief Medical Officer of RSM Diagnostic Labs and ReligenDx, to explore what today's gut testing can—and can't—tell us.Sri Ganeshan, MD is a gastroenterologist, physician-scientist, and the Chief Medical Officer of RSM Diagnostic Labs and ReligenDx. His work focuses on advancing laboratory diagnostics through clinically actionable testing, with expertise in gastrointestinal health, microbiome science, mitochondrial function, and precision medicine.Together, they unpack the science behind stool testing, the differences between PCR and culture-based testing, and why clinically actionable results matter more than simply collecting more data. They also discuss the microbiome, digestive function, parasite testing, pancreatic health, probiotics, emerging AI technology in laboratory diagnostics, and the current evidence surrounding repurposed medications like ivermectin.Whether you're a patient looking to better understand your gut health or a healthcare professional interested in the future of functional diagnostics, this conversation offers practical insights grounded in clinical experience and scientific evidence.In This EpisodePCR vs. culture stool testingWhy "more testing" isn't always betterHow clinicians interpret microbiome resultsFunctional markers that may matter more than bacteria aloneThe role of pancreatic elastase and digestive functionParasite testing: facts vs. social media mythsWhat we know—and don't know—about ivermectin in cancer careThe future of AI in laboratory medicineWhy healthy habits still matter most for gut healthChapters00:00 – Introduction00:56 – Meet Sri Ganeshan, MD02:10 – PCR vs. Culture: What's the Difference?07:27 – Are We Overcomplicating Gut Testing?11:15 – The Problem with Chasing One Lab Value14:15 – Functional Gut Markers That Matter16:11 – Why Pancreatic Elastase Is Often Overlooked18:17 – Parasites: Separating Fact from Fiction22:06 – Ivermectin and Repurposed Medications27:44 – What Today's Gut Tests Can Actually Tell Us29:13 – EMFs, the Microbiome & Emerging Questions32:08 – Why Food Still Matters Most33:18 – Final ThoughtsSubscribe to Rubin On Point for conversations about cancer resilience, functional medicine, longevity, and what it truly means to be human.#RubinOnPoint #GutHealth #Microbiome #FunctionalMedicine #DigestiveHealth #IntegrativeMedicine #PrecisionMedicine #CancerResilience #Podcast
Can a cancer diagnosis become the catalyst for changing healthcare forever?
In this episode of Rubin On Point, Dr. Dan Rubin sits down with Ivelisse Page, Executive Director and Co-founder of the Believe Big Foundation, a nonprofit organization dedicated to bridging conventional and integrative oncology.
After overcoming both stage IV colon cancer and endometrial cancer without chemotherapy, Ivelisse has devoted her life to patient advocacy, advancing mistletoe therapy research, and expanding access to whole-person cancer care.
Together, they explore her remarkable journey—from receiving an 8% chance of survival to becoming a driving force behind integrative cancer research and compassionate patient support.
Ivelisse shares how one moment in a hospital waiting room inspired the creation of Believe Big, the role mistletoe therapy played in her healing, and her vision for the Believe Big Institute of Health, an innovative model designed to make integrative oncology more accessible for patients everywhere.
The conversation also explores the emotional and spiritual aspects of healing, the importance of community, and why resilience is about much more than simply surviving cancer.
Whether you're navigating a cancer diagnosis, supporting a loved one, or
passionate about the future of integrative medicine, this episode offers hope, inspiration, and a powerful reminder that healing happens on many levels.
In this episode, you'll learn about:
• Ivelisse's personal cancer recovery journey and healing philosophy
• The mistletoe clinical trials she helped initiate with Johns Hopkins University
• The vision behind the Believe Big Institute of Health and its patient-centered programs
• Why addressing the physical, emotional, and spiritual aspects of healing matters
• How resilience, purpose, and community can transform the cancer experience
If you're interested in learning more about Believe Big's work, join the Believe Big Integrative Cancer Symposium on October 17 in Towson, Maryland, where leading experts in integrative oncology will share the latest research and clinical insights.
Ivelisse and her husband have also launched Wellness Home Direct, a professional-grade wellness marketplace featuring carefully curated products to support health and healing.
Learn more:
🤍 Believe Big Foundation: https://believebig.org
🤍 Believe Big Integrative Cancer Symposium: https://believebig.org
🤍 Wellness Home Direct: https://www.wellnesshomedirect.com
Chapters
00:00 Intro
00:43 Meet Ivelisse Page
02:25 The vision for an integrative cancer hospital
06:07 Healing beyond medicine: emotional and spiritual care
10:03 Her stage IV colon cancer diagnosis
13:24 The symptoms that changed everything
16:24 Choosing an individualized approach to treatment
17:23 Receiving an 8% chance of survival
19:20 Discovering mistletoe therapy
20:50 Liver surgery and the road to recovery
22:00 The Africa mission trip that reshaped her purpose
26:51 The waiting room that inspired Believe Big
28:25 The story behind the Believe mugs
30:20 Overcoming fear during cancer treatment
32:30 Becoming cancer-free
36:21 Funding the first Johns Hopkins mistletoe clinical trial
38:53 Why the organization is called Believe Big
41:27 EMF protection and resilience
42:32 Final thoughts on hope and healing
43:05 Outro
What if death is not a biological certainty, but a problem that science could eventually solve?
In this fascinating episode of Rubin On Point, Dr. Dan Rubin sits down with James Strole, founder of People Unlimited and the Coalition for Radical Life Extension, to explore one of humanity's oldest and most controversial questions:
Can humans achieve unlimited lifespans?
For decades, he has been a leading advocate for the concept of unlimited lifespans and human life extension through scientific innovation, personal transformation, and evolving consciousness. James has spent more than 50 years advocating for radical life extension and believes we are entering an era where breakthroughs in longevity science, gene therapies, regenerative medicine, and human consciousness could fundamentally change our relationship with aging and death. His upcoming book, The Gospel of Longevity, explores the intersection of longevity science, spirituality, and the future of human potential.
Together, Dr. Rubin and James dive into a wide-ranging discussion on:
• The difference between longevity and immortality
• Whether aging can be reversed
• Telomeres, gene therapies, and emerging anti-aging technologies
• The ethical and societal implications of unlimited lifespans
• Overpopulation, economics, and the future of humanity
• Cancer, immune function, and resilience
• Spirituality, consciousness, and the meaning of death
• The influence of Jesus and faith on James's longevity philosophy
• Whether death is a biological reality or a limitation we can overcome
This episode challenges conventional thinking and explores what the future might look like if humans no longer viewed aging and death as unavoidable.
Whether you agree, disagree, or find yourself somewhere in the middle, this conversation is guaranteed to make you think.
Connect with James Strole
The Gospel of Longevity
www.thegospeloflongevity.com
People Unlimited
www.peopleunlimitedinc.com
Instagram: @James.Strole
𝕏: @JamesRstrole
Facebook: @james.strole.520
LinkedIn: JamesStrole
Upcoming Event
🎤 RAADfest 2026 – Revolution Against Aging and Death
📅 September 4–6, 2026 📍 Talking Stick Resort | Scottsdale, Arizona
Learn more: www.RAADfest.com
About Rubin On Point
Rubin On Point is a podcast about cancer resilience, health optimization, personal transformation, and what it truly means to be human. Through conversations with innovators, scientists, physicians, and thought leaders, Dr. Dan Rubin explores the ideas shaping the future of health and longevity.
CHAPTERS
00:00 Introduction
00:43 Meet James Strole
02:08 What Is Radical Life Extension?
03:28 Are We Entering the Age of Immortality?
05:13 The Benefits and Risks of Unlimited Lifespans
09:23 Politics, Economics, and Longevity
14:21 Overpopulation and the Future of Humanity
19:20 Why Do Humans Age and Die?
20:53 Spirituality, Jesus, and Longevity
26:36 Can Humanity End Death?
30:25 Do You Need Faith to Live Forever?
33:43 Cancer, Aging, and the Future of Medicine
38:06 Is the Human Body the Ultimate Expression of Life?
40:28 The Gospel of Longevity
41:13 Final Thoughts
#Longevity #Immortality #AntiAging #LifeExtension #JamesStrole #RAADfest #CancerResilience #Healthspan #FutureOfMedicine #Aging #HumanPotential #RubinOnPoint
Welcome back to Rubin On Point.
This week, Dr. Dan Rubin sits down with Daniel Boenning, B.S., CCN, a Certified Clinical Nutritionist and Biotics Research representative with nearly three decades of experience in the nutritional supplement industry.
A graduate of the University of Wisconsin–Madison with a degree in Biochemistry of Nutrition, Daniel began his career working in a highly integrative medical practice before moving to Arizona, where he has spent the last 28 years educating practitioners and helping shape conversations around nutrition, supplementation, and patient care.
Together, Dan and Daniel explore what most people never see behind the supplement label—from manufacturing standards and quality control to contamination concerns, misleading marketing claims, and the growing challenge of navigating health information in the age of AI and social media.
They also discuss foundational nutrition, environmental stressors, mentorship, and why integrity still matters in an industry that continues to grow at a rapid pace.
Whether you're a healthcare practitioner, someone navigating a complex health journey, or simply trying to make more informed decisions about supplements, this episode offers a rare insider perspective on an industry that impacts millions of lives every day.
Chapters
00:00 Introduction
00:43 Meet Daniel Boenning
08:29 How the Supplement Industry Has Changed
11:15 What Makes a Quality Supplement Different
15:04 Whole-Food Minerals and Nutrient Delivery
17:15 Inside Supplement Testing and Quality Control
20:20 Contamination, Mislabeling, and Industry Challenges
28:23 Why Practitioners Recommend Specific Brands
29:01 The Growing Concern Over Counterfeit Supplements
30:51 The Missing Foundation of Modern Health
34:55 EMFs and Environmental Stressors
40:22 AI, Social Media, and Supplement Misinformation
42:20 The Mentor Who Shaped a Generation
44:28 Final Thoughts on Quality, Integrity, and Healthcare
Connect with Rubin On Point:
🎙️ YouTube: @RubinOnPointPodcast
📱 Instagram: @RubinOnPointPodcast
Subscribe for new conversations exploring resilience, integrative medicine, human performance, and the stories that shape how we heal.
What happens when life forces you to rebuild everything—your health, your identity, your relationships, and your future?In this deeply personal Patient Perspectives episode of Rubin On Point, Dr. Dan Rubin sits down with Micalyn McCready to unpack her extraordinary journey through tongue cancer, lung metastasis, brain lesions, radiation, immunotherapy, infections, seizures, and ultimately… remission.Micalyn shares what it was like to undergo tongue reconstruction surgery, relearn speech, navigate years of treatment, and completely reevaluate who and what truly mattered in her life. From losing friendships to discovering resilience, environmental health, and self-advocacy, this episode is an honest conversation about survival—and the mindset that carried her through it all.This is not just a cancer story.It’s a story about identity, perspective, and becoming stronger through unimaginable adversity.Topics Covered:* Tongue cancer diagnosis & reconstruction surgery* Living with an “arm tongue”* Radiation & immunotherapy treatment* Brain lesions, seizures, and hospitalizations* The emotional reality of survivorship* Friendships, support systems & boundaries* Environmental toxins, PFAS & heavy metals* Mindset, resilience & rebuilding life after cancerChapters:00:00 – Introduction01:05 – Meeting Micalyn & her diagnosis03:20 – Discovering tongue cancer10:37 – Life after tongue reconstruction surgery14:24 – Radiation treatment & recovery16:34 – Lung metastasis & immunotherapy21:28 – How cancer changed relationships25:05 – Redefining priorities & identity29:14 – Brain lesions & seizures36:02 – Severe infections & complications41:12 – Environmental toxins & PFAS discussion44:26 – Living cancer free
What if your immune system already knows how to fight cancer… it just needs the right instructions?
In this episode of Rubin On Point, Dr. Dan Rubin sits down with Rafael Gonzalez, regenerative medicine expert and Lead Scientific Advisor for Immunocine, to unpack one of the most advanced frontiers in oncology: dendritic cell therapy.
Immunocine is focused on personalized dendritic cell immunotherapy—using an individual’s own tumor biology to help train the immune system to
recognize and target cancer with precision. This conversation breaks down how cellular therapies are shifting oncology toward personalization, immune intelligence, and biologically driven treatment strategies.
Together, they explore:
• Why dendritic cells are considered the “command center” of the immune system
• The difference between immune stimulation vs. true immune targeting
• How natural killer (NK) cells help eliminate damaged and aging cells
• The role of exosomes and cellular communication in healing and disease
• Why preserving tumor tissue may become a critical part of future cancer care
They also discuss Immunocine Preserve, a tumor tissue preservation program designed to store biopsy or surgical tumor samples for potential future use in personalized immunotherapy and emerging cellular therapies. Because many biopsies are not preserved correctly for future immune-based treatments, this process gives people the opportunity to preserve valuable tumor biology before it’s lost.
This is a deep, honest conversation about where oncology, immunology, and regenerative medicine are heading next—and what it means for people navigating a cancer diagnosis today.
🔗 Learn more about Immunocine:
Immunocine.com
🔗 Learn more about Immunocine Preserve:
ImmunocinePreserve.com
#RubinOnPoint #Immunotherapy #DendriticCellTherapy #IntegrativeOncology #CancerCare #PrecisionMedicine #ImmuneHealth
⏱ Chapters
00:00 – Intro: Cancer, resilience, and being human
01:03 – Who is Dr. Rafael Gonzalez?
02:42 – What “vaccine” really means in immunology
08:15 – What is dendritic cell therapy?
10:02 – How tumors are used to train the immune system
12:53 – Why tumor preservation matters (Immunocine Preserve)
17:06 – Why most biopsies can’t be used later
19:09 – How the treatment process works
22:49 – Natural killer (NK) cells explained
23:19 – What are “zombie cells” (senescence)?
26:33 – Anti-aging + immune system connection
28:30 – Engineering NK cells for therapy
35:56 – What are exosomes (and why they matter)?
41:06 – Risks in the exosome space
44:18 – Why NK cells may be the future
47:10 – Final thoughts on cellular therapy
Rewriting Recovery: A Human-First Approach to Addiction & Mental Health
What if the biggest problem in addiction recovery… is the way we treat it?
In this powerful episode of Rubin On Point, Dr. Dan Rubin sits down with Hamilton Baiden, CEO & Founder of YouTurn Health, to challenge everything we think we know about behavioral health, substance use, and recovery.
Hamilton shares his deeply personal journey—from a high-functioning executive battling addiction to building a nationwide virtual platform designed to close the gaps traditional treatment leaves behind.
This conversation goes beyond addiction—it’s about human connection, stigma, family impact, and why most people never get help in the first place.
If you’ve ever struggled—or loved someone who has—this episode is for you.
⏱️ Chapters
00:00 – Introduction to Rubin On Point
00:42 – Meet Hamilton Baiden & YouTurn Health
01:39 – Addiction from the inside: “I was a normal guy”
04:04 – The moment everything changed (getting sober)
06:01 – The real problem with traditional treatment
06:38 – Why 90% of people never ask for help
07:56 – The forgotten victims: family members
09:21 – The shocking truth about treatment adherence
10:38 – Building a system that actually works
12:33 – Why “just quit” doesn’t work
14:02 – Human-first care vs. institutional models
16:15 – Why virtual support is more effective than you think
17:23 – The power of real-time connection
18:42 – Supporting families through addiction
20:02 – Meeting people where they are (not where we want them to be)
22:01 – Mental health vs. substance use: what’s different?
24:30 – “Netflix for behavioral health” explained
26:33 – Why people don’t want therapy—but still need help
27:10 – Stress, anxiety, and long-term health consequences
28:15 – The family perspective: healing both sides
30:25 – Neurobiology of addiction explained
32:05 – Psychedelics, research, and future treatment
34:21 – Social media, dopamine & rising anxiety
36:09 – What addiction actually looks like day-to-day
38:14 – The emotional toll: anxiety, depression, and memory gaps
39:36 – The truth about sobriety (no clichés)
41:25 – Redefining recovery: does everyone need to quit?
43:06 – Can people learn to drink responsibly?
44:17 – Why one-size-fits-all treatment fails
44:35 – Final thoughts: changing the future of recovery
Cancer isn’t just about mutations.
In Part 2 of this conversation, Dr. Brandon Guida breaks down how epigenomics is transforming the way we detect, monitor, and understand cancer in real time.
If Part 1 explained the “operating system,” this episode shows how that system becomes a fingerprint for disease—and how we can actually measure it.
We dive into:
This is where diagnostics meet precision medicine.
And where the future of oncology is heading.
⏱️ CHAPTERS
00:00 – Welcome back + Part 1 recap
00:52 – Epigenomics in cancer: what changes
53:31 – Cancer “fingerprints” explained
54:29 – Multi-cancer early detection tests
55:14 – ctDNA vs cfDNA (the “haystack” analogy)
57:20 – The future: multi-modal diagnostics
58:04 – Why epigenomics improves detection sensitivity
01:00:11 – Mutations vs epigenetic changes
01:01:20 – Why methylation gives more signal
01:02:32 – BRCA: mutation vs epigenetic silencing
01:04:09 – Why testing matters (if you’re looking for it)
01:07:18 – Tp53 explained (and why it’s a big deal)
01:13:58 – Clonal evolution + treatment resistance
01:15:50 – Tumor fraction: how it’s calculated
01:16:52 – When treatment looks like it’s working—but isn’t
01:18:10 – Why clinicians aren’t using this enough (yet)
What if your DNA isn’t your destiny?
In Part 1 of this conversation, Dr. Dan Rubin sits down with molecular diagnostics expert Dr. Brandon Guida to break down epigenomics—the system that controls how your genes are actually expressed.
This is the layer above your DNA… the one that decides what gets turned on, turned off, and when.
If genetics are the blueprint, epigenomics is the operating system.
And it’s constantly changing.
In this episode, we unpack:
This is foundational. And it sets the stage for how we think about cancer, resilience, and personalized medicine.
⏱️ CHAPTERS
00:00 – Welcome to Rubin On Point
00:42 – Introducing Dr. Brandon Guida
01:23 – What is epigenomics (really)?
02:23 – Why DNA methylation is oversimplified
03:17 – MTHFR vs. epigenomics (key distinction)
05:04 – Genotype vs. phenotype explained
06:30 – The origin of epigenetics (Waddington’s model)
09:07 – How methylation actually turns genes on/off
10:31 – The “iPhone” analogy for your biology
13:42 – Genes vs. epigenome: who’s in control?
14:59 – Can your epigenome be changed?
18:02 – Epigenetic “memory” and environmental impact
19:55 – What happens in cancer (epigenetically)
22:28 – Tumor suppressor genes + methylation
23:41 – Why this matters clinically (Part 2 preview)
From the publisher's feed